Search results
Results from the WOW.Com Content Network
That momentum helped fuel a record quarter for pharmacy sales during which CVS filled 432 million subscriptions, up 9% from Q3 2023, increasing its market share of scripts filled nationally to 27.3%.
On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...
CVS is the top U.S. pharmacy in terms of prescription drug revenue, holding more than 25% of the market share in 2023, according to Statista data released in March. Walgreens trailed behind with ...
On Wednesday, CVS Health Corp (NYSE:CVS) reported first-quarter sales of $88.4 billion, up 3.7% year over year, missing the consensus of $89.21 billion. This was largely due to strong growth in ...
As of 11:52 a.m. ET, the stock was up 14.5% on the news. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now.
(Reuters) -CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed for drugs, in a push for more ...
CVS, which has a market value of about $79 billion and held long-term debt of roughly $58 billion at the end of December, in August lowered its annual profit forecast to $6.40 to $6.65 per share ...
CVS Health (CVS) closed the most recent trading day at $63.47, moving +0.06% from the previous trading session.